Aceragen | Resultado Líquido



Net Income Alterar Data
Abbott USD 1.33B 7.9B 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Cipla INR 12.22B 3.49B 2025-03
Clal Biotechnology ILS -6166000 15.56M 2022-12
Compugen USD -6117000 7.39M 2024-12
CSL USD 2.01B 1.27B 2024-12
Dynavax Technologies USD -96099000 103.15M 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Grifols EUR 68.97M 17.28M 2024-12
Merck USD 5.08B 1.34B 2025-03
Pfizer USD 2.97B 2.56B 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
X T L Biopharmaceuticals USD -255000 298K 2024-12



Aceragen Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.